SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Alcohol Helps the Brain Remember, Says New University of Texas Study
April 12, 2011
 · 
1 min read
Lone Star Bio
‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells, University of Texas MD Anderson Cancer Center Reveals
April 12, 2011
 · 
1 min read
Lone Star Bio
Blueberries May Inhibit Development of Fat Cells, Texas Woman’s University Study
April 11, 2011
 · 
1 min read
Lone Star Bio
Dangerous Blood Pressure Increases During Exercise Can be Blocked, UT Southwestern Medical Center Study
April 5, 2011
 · 
1 min read
Lone Star Bio
Potential New Non-Insulin Treatment for Type 1 Diabetes Found, UT Southwestern Medical Center Study Reveals
March 25, 2011
 · 
3 min read
Lone Star Bio
Nanomaterial Bulks Up Under Stress, Rice University Study Reveals
March 24, 2011
 · 
1 min read
Lone Star Bio
Menthol Cigarette Less Likely to Cause Lung Cancer? - Vanderbilt University and Meharry Medical College Study Reveals
March 24, 2011
 · 
1 min read
Lone Star Bio
Drug Prevents Type 2 Diabetes in Majority of High-Risk Individuals, Pennington Biomedical Research Center Study Finds
March 24, 2011
 · 
1 min read
Lone Star Bio
Transistor Performance Improves Due to Quantum Confinement Effects, University of Texas Study
March 22, 2011
 · 
1 min read
Lone Star Bio
Stem Cell Therapy Shrinks Enlarged Hearts, University of Miami Study
March 18, 2011
 · 
4 min read
Load More
PRESS RELEASES
Press Releases
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
February 19, 2026
 · 
7 min read
Press Releases
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
February 19, 2026
 · 
31 min read
Press Releases
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer
February 19, 2026
 · 
5 min read
Press Releases
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
February 19, 2026
 · 
3 min read
Press Releases
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 19, 2026
 · 
5 min read
Press Releases
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
February 18, 2026
 · 
4 min read
Press Releases
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
 · 
3 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
 · 
10 min read
Press Releases
Medicenna Therapeutics Announces Participation in Upcoming Conferences
February 18, 2026
 · 
4 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
 · 
1 min read
Load More